Dark Forest Capital Management LP Arcturus Therapeutics Holdings Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$25.44 - $37.35 $220,717 - $324,048	-8,676 Reduced 25.59%	25,228 $644,000
Q2 2023 Aug 14, 2023	BUY	$23.94 - $32.36 $633,835 - $856,763	26,476 Added 356.44%	33,904 $972,000
Q1 2023 May 12, 2023	BUY	$14.72 - $23.97 $100,213 - $163,187	6,808 Added 1098.06%	7,428 $178,000
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $8,766 - $14,297	620 New	620 $10,000
Q1 2022 May 13, 2022	SELL	$17.64 - $39.57 $17 - $39	-1 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$34.2 - $47.56 $10,191 - $14,172	-298 Reduced 99.67%	1 $0
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $8,336 - $17,416	299 New	299 $14,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $411M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.